BTCY vs. PETV, PSTV, GCTK, NURO, MBOT, NXGL, INBS, GBS, SSKN, and VVOS
Should you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include PetVivo (PETV), Plus Therapeutics (PSTV), GlucoTrack (GCTK), NeuroMetrix (NURO), Microbot Medical (MBOT), NEXGEL (NXGL), Intelligent Bio Solutions (INBS), GBS (GBS), STRATA Skin Sciences (SSKN), and Vivos Therapeutics (VVOS). These companies are all part of the "surgical & medical instruments" industry.
PetVivo (NASDAQ:PETV) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.
24.6% of PetVivo shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 20.1% of PetVivo shares are held by insiders. Comparatively, 20.5% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
PetVivo has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.
In the previous week, Biotricity had 1 more articles in the media than PetVivo. MarketBeat recorded 1 mentions for Biotricity and 0 mentions for PetVivo. PetVivo's average media sentiment score of 0.29 beat Biotricity's score of 0.00 indicating that Biotricity is being referred to more favorably in the news media.
PetVivo and Biotricity both received 0 outperform votes by MarketBeat users.
PetVivo has higher earnings, but lower revenue than Biotricity. PetVivo is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.
Biotricity has a net margin of -125.43% compared to Biotricity's net margin of -1,016.64%. PetVivo's return on equity of 0.00% beat Biotricity's return on equity.
Summary
Biotricity beats PetVivo on 8 of the 13 factors compared between the two stocks.
Get Biotricity News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Biotricity Competitors List
Related Companies and Tools
